HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Christos Emmanouilides Selected Research

Yttrium

9/2007Weight-based dosing of Yttrium 90 ibritumomab tiuxetan in patients with relapsed or refractory B-cell non-Hodgkin lymphoma.
5/2007Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan.
4/2006Treatment with yttrium 90 ibritumomab tiuxetan at early relapse is safe and effective in patients with previously treated B-cell non-Hodgkin's lymphoma.
12/2004Antilymphoma treatments given subsequent to Yttrium 90 ibritumomab tiuxetan are feasible in patients with progressive non-Hodgkin's lymphoma: a review of the literature.
9/2004Yttrium 90-labeled ibritumomab tiuxetan radioimmunotherapy produces high response rates and durable remissions in patients with previously treated B-cell lymphoma.
8/2003Radioimmunotherapy for non-Hodgkin's lymphoma.
2/2002Yttrium 90 ibritumomab tiuxetan radioimmunotherapy for relapsed or refractory low-grade non-Hodgkin's lymphoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Christos Emmanouilides Research Topics

Disease

24Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2009 - 02/2002
13Lymphoma (Lymphomas)
01/2009 - 09/2002
12Neoplasms (Cancer)
08/2015 - 05/2002
6B-Cell Lymphoma (Lymphoma, B Cell)
11/2007 - 09/2002
5Waldenstrom Macroglobulinemia (Macroglobulinemia)
04/2009 - 04/2003
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
09/2007 - 04/2003
3Colorectal Neoplasms (Colorectal Cancer)
11/2008 - 01/2007
3Hodgkin Disease (Hodgkin's Disease)
01/2004 - 08/2003
2Lung Neoplasms (Lung Cancer)
08/2015 - 03/2015
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2010 - 07/2008
2Neutropenia
01/2010 - 07/2005
2Neoplasm Metastasis (Metastasis)
01/2008 - 12/2003
2Hematologic Neoplasms (Hematological Malignancy)
07/2007 - 01/2006
2Stomatitis
11/2006 - 12/2004
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2006 - 07/2005
1Ischemia
08/2015
1Thrombosis (Thrombus)
08/2015
1Pulmonary Embolism
06/2015
1Renal Cell Carcinoma (Grawitz Tumor)
06/2015
1Venous Thrombosis (Deep-Vein Thrombosis)
06/2015
1B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
11/2008
1Chromosome Aberrations (Chromosome Abnormalities)
09/2007
1Myelodysplastic Syndromes (Myelodysplastic Syndrome)
09/2007
1Graft vs Host Disease (Graft-Versus-Host Disease)
06/2006
1Cytomegalovirus Infections (Inclusion Disease)
06/2006
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2006
1Hairy Cell Leukemia
01/2006
1Multiple Myeloma
01/2006
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2006
1Anemia
07/2005
1Mucositis
12/2004
1Body Weight (Weight, Body)
12/2004
1Infection
09/2004
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell)
06/2004
1Thrombocytopenia (Thrombopenia)
04/2003

Drug/Important Bio-Agent (IBA)

15ibritumomab tiuxetan (Zevalin)FDA Link
01/2009 - 02/2002
14rituximab (Mabthera)FDA Link
04/2009 - 05/2002
7YttriumIBA
09/2007 - 02/2002
4bevacizumabFDA Link
06/2015 - 01/2007
2InterferonsIBA
06/2015 - 01/2006
2oxaliplatin (Eloxatin)FDA LinkGeneric
11/2008 - 01/2007
2Fibroblast Growth Factor 7FDA Link
11/2006 - 12/2004
2CD20 AntigensIBA
04/2006 - 04/2003
2gemcitabineFDA Link
06/2004 - 12/2002
2Glucose (Dextrose)FDA LinkGeneric
01/2004 - 07/2003
2Paclitaxel (Taxol)FDA LinkGeneric
11/2003 - 12/2002
2Immunoglobulin M (IgM)IBA
04/2003 - 04/2003
1Heparin (Liquaemin)FDA LinkGeneric
08/2015
1Alprostadil (Muse)FDA LinkGeneric
08/2015
1Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA
06/2015
1everolimusFDA Link
06/2015
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2015
1pemetrexed (MTA)FDA Link
01/2010
1Folic Acid (Vitamin M)FDA LinkGeneric
01/2010
1fludarabineIBA
04/2009
1hLL2 agent (epratuzumab)IBA
11/2008
1SodiumIBA
11/2008
1Toll-Like Receptor 9IBA
10/2007
1ProMune (CpG 7909)IBA
10/2007
1purineIBA
09/2007
1Alkylating AgentsIBA
09/2007
1Monoclonal AntibodiesIBA
05/2007
1Fluorouracil (Carac)FDA LinkGeneric
01/2007
1Leucovorin (Folinic Acid)FDA Link
01/2007
1Interleukin-2 (IL2)IBA
12/2006
1valganciclovirFDA Link
06/2006
1Ganciclovir (Cytovene)FDA LinkGeneric
06/2006
1bortezomib (Velcade)FDA Link
01/2006
1gemtuzumab (gemtuzumab ozogamicin)FDA Link
01/2006
1Thalidomide (Thalomid)FDA Link
01/2006
1Proteasome Endopeptidase Complex (Proteasome)IBA
01/2006
1galiximabIBA
07/2005
1Opioid Analgesics (Opioids)IBA
12/2004
1Morphine (MS Contin)FDA LinkGeneric
12/2004
1Itraconazole (Sporanox)FDA LinkGeneric
09/2004
1Dexamethasone (Maxidex)FDA LinkGeneric
06/2004
1Cisplatin (Platino)FDA LinkGeneric
06/2004
1Interleukin-10 (Interleukin 10)IBA
04/2004
1Immunoconjugates (Immunoconjugate)IBA
08/2003
1AntigensIBA
04/2003
1vinorelbine (Navelbine)FDA LinkGeneric
12/2002
1Mitoxantrone (Novantrone)FDA LinkGeneric
09/2002
1IfosfamideFDA LinkGeneric
09/2002
1Etoposide (VP 16)FDA LinkGeneric
09/2002

Therapy/Procedure

14Radioimmunotherapy
01/2009 - 02/2002
8Drug Therapy (Chemotherapy)
01/2009 - 12/2002
5Transplants (Transplant)
08/2015 - 12/2003
4Transplantation (Transplant Recipients)
08/2015 - 09/2004
4Aftercare (After-Treatment)
09/2007 - 04/2003
3Stem Cell Transplantation
04/2006 - 09/2002
2Replantation
08/2015 - 03/2015
2Pneumonectomy (Lung Volume Reduction)
03/2015 - 01/2008
2Immunotherapy
01/2009 - 05/2002
2Hematopoietic Stem Cell Transplantation
11/2006 - 12/2004
1Adrenalectomy
01/2008
1Autologous Transplantation
04/2006
1Radiotherapy
12/2004
1Total Parenteral Nutrition
12/2004